Found: 44
Select item for more details and to access through your institution.
Telomeres and telomerase in hematologic neoplasia.
- Published in:
- Oncogene, 2002, v. 21, n. 4, p. 680, doi. 10.1038/sj.onc.1205075
- By:
- Publication type:
- Article
Exosomal miRNA Signatures for Late-Onset Acute Graft-Versus-Host Disease in Allogenic Hematopoietic Stem Cell Transplantation.
- Published in:
- International Journal of Molecular Sciences, 2018, v. 19, n. 9, p. 2493, doi. 10.3390/ijms19092493
- By:
- Publication type:
- Article
Downregulation of Plasma miR-215 in Chronic Myeloid Leukemia Patients with Successful Discontinuation of Imatinib.
- Published in:
- International Journal of Molecular Sciences, 2016, v. 17, n. 4, p. 570, doi. 10.3390/ijms17040570
- By:
- Publication type:
- Article
Non-radioisotopic and Semi-quantitative Procedure for Terminal Repeat Amplification Protocol.
- Published in:
- Cancer Science, 1996, v. 87, n. 4, p. 329, doi. 10.1111/j.1349-7006.1996.tb00225.x
- By:
- Publication type:
- Article
Philadelphia Chromosome-positive Chronic Myelogenous Leukemia with Deleted Fusion of BCR and ABL Genes.
- Published in:
- Cancer Science, 1990, v. 81, n. 1, p. 35, doi. 10.1111/j.1349-7006.1990.tb02504.x
- By:
- Publication type:
- Article
Hematologic and Cytogenetic Findings in Myelodysplastic Syndromes Treated with Recombinant Human Granulocyte Colony-stimulating Factor.
- Published in:
- Cancer Science, 1989, v. 80, n. 9, p. 848, doi. 10.1111/j.1349-7006.1989.tb01725.x
- By:
- Publication type:
- Article
MORPHOLOGIC CHANGES OF NEUTROPHILS IN MYELODYSPLASTIC SYNDROME TREATED WITH RECOMBINANT HUMAN GRANULOCYTE COLONY-STIMULATING FACTOR.
- Published in:
- Cancer Science, 1988, v. 79, n. 7, p. 813, doi. 10.1111/j.1349-7006.1988.tb00041.x
- By:
- Publication type:
- Article
Establishment of a new Epstein-Barr virus nuclear antigen-positive B-cell line, BALL-2, with t(8;14)(q24;q32) chromosome abnormality from B-cell acute lymphoblastic leukemia, L2.
- Published in:
- American Journal of Hematology, 1991, v. 37, n. 3, p. 179, doi. 10.1002/ajh.2830370309
- By:
- Publication type:
- Article
Correction of anemia by recombinant human erythropoietin in a patient with polycythemia vera associated with hemodialysis-dependent chronic renal failure.
- Published in:
- American Journal of Hematology, 1991, v. 37, n. 2, p. 141, doi. 10.1002/ajh.2830370222
- By:
- Publication type:
- Article
Acute lymphoblastic leukemia with azurophilic granules that contain ultrastructural myeloperoxidase activity.
- Published in:
- American Journal of Hematology, 1991, v. 36, n. 4, p. 288, doi. 10.1002/ajh.2830360414
- By:
- Publication type:
- Article
CD4+ and CD56+ acute monoblastic leukemia.
- Published in:
- American Journal of Hematology, 1990, v. 34, n. 3, p. 228, doi. 10.1002/ajh.2830340315
- By:
- Publication type:
- Article
Myelodysplastic syndrome with trisomy 11 associated with polycythemia vera.
- Published in:
- American Journal of Hematology, 1989, v. 31, n. 2, p. 122, doi. 10.1002/ajh.2830310209
- By:
- Publication type:
- Article
Testicular tumor as the first manifestation of B-lymphoid blastic crisis in a case of Ph-positive chronic myelogenous leukemia.
- Published in:
- American Journal of Hematology, 1988, v. 29, n. 3, p. 164, doi. 10.1002/ajh.2830290308
- By:
- Publication type:
- Article
Activity of a novel G-quadruplex-interactive telomerase inhibitor, telomestatin (SOT-095), against human leukemia cells: involvement of ATM-dependent DNA damage response pathways.
- Published in:
- Oncogene, 2003, v. 22, n. 34, p. 5338, doi. 10.1038/sj.onc.1206833
- By:
- Publication type:
- Article
A novel non-invasive monitoring assay of 5-azacitidine efficacy using global DNA methylation of peripheral blood in myelodysplastic syndrome.
- Published in:
- Drug Design, Development & Therapy, 2019, v. 13, p. 1821, doi. 10.2147/DDDT.S195071
- By:
- Publication type:
- Article
Downregulation of extracellular vesicle microRNA-101 derived from bone marrow mesenchymal stromal cells in myelodysplastic syndrome with disease progression.
- Published in:
- Oncology Letters, 2020, v. 19, n. 3, p. 2053, doi. 10.3892/ol.2020.11282
- By:
- Publication type:
- Article
The BCL2L11 ( BIM) deletion polymorphism is a possible criterion for discontinuation of imatinib in chronic myeloid leukaemia patients.
- Published in:
- British Journal of Haematology, 2013, v. 160, n. 2, p. 269, doi. 10.1111/bjh.12111
- By:
- Publication type:
- Article
Increased natural killer cells and decreased CD3<sup>+</sup>CD8<sup>+</sup>CD62L<sup>+</sup> T cells in CML patients who sustained complete molecular remission after discontinuation of imatinib.
- Published in:
- British Journal of Haematology, 2012, v. 157, n. 2, p. 254, doi. 10.1111/j.1365-2141.2011.08939.x
- By:
- Publication type:
- Article
PNH-phenotype cells in patients with idiopathic cytopenia of undetermined significance (ICUS) with megakaryocytic hypoplasia and thrombocytopenia.
- Published in:
- 2010
- By:
- Publication type:
- Letter
Interleukin 6 receptor expression by human cord blood- or peripheral blood-derived primitive haematopoietic progenitors implies acquisition of different functional properties.
- Published in:
- British Journal of Haematology, 2000, v. 110, n. 2, p. 327, doi. 10.1046/j.1365-2141.2000.02148.x
- By:
- Publication type:
- Article
Association Between ApoE Phenotypes and Telomere Erosion in Alzheimer’s Disease.
- Published in:
- Journals of Gerontology Series A: Biological Sciences & Medical Sciences, 2012, v. 67A, n. 4, p. 330, doi. 10.1093/gerona/glr185
- By:
- Publication type:
- Article
Downregulated microRNA-l48b in circulating PBMCs in chronic myeloid leukemia patients with undetectable minimal residual disease: a possible biomarker to discontinue imatinib safely.
- Published in:
- Drug Design, Development & Therapy, 2014, v. 8, p. 1151, doi. 10.2147/DDDT.S66812
- By:
- Publication type:
- Article
Clinical Impact of Down-Regulated Plasma miR-92a Levels in Non-Hodgkin's Lymphoma.
- Published in:
- PLoS ONE, 2011, v. 6, n. 2, p. 1, doi. 10.1371/journal.pone.0016408
- By:
- Publication type:
- Article
Effect of the extracellular component of bone marrow mesenchymal stromal cells from healthy donors on hematologic neoplasms and their angiogenesis.
- Published in:
- Human Cell, 2020, v. 33, n. 3, p. 599, doi. 10.1007/s13577-020-00332-y
- By:
- Publication type:
- Article
Detection of Low Allele Burden of JAK2 Exon 12 Mutations Using TA-cloning in Patients with Erythrocytosis.
- Published in:
- Japanese Journal of Clinical Oncology, 2009, v. 39, n. 8, p. 509, doi. 10.1093/jjco/hyp048
- By:
- Publication type:
- Article
Isolated Erythrocythemia: A Distinct Entity or a Sub-type of Polycythemia Vera?
- Published in:
- Japanese Journal of Clinical Oncology, 2008, v. 38, n. 3, p. 230, doi. 10.1093/jjco/hym174
- By:
- Publication type:
- Article
Multiple Pulmonary Nodules Caused by B-Cell Post-transplant Lymphoproliferative Disorder after Bone Marrow Transplantation: Monitoring Epstein–Barr Virus Viral Load.
- Published in:
- Japanese Journal of Clinical Oncology, 2003, v. 33, n. 8, p. 408, doi. 10.1093/jjco/hyg081
- By:
- Publication type:
- Article
A Possible Correlation between Interferon-stimulated Gene Expression and Cytogenetic Responses in Chronic Myelogenous Leukemia Patients Treated with α-interferon.
- Published in:
- Japanese Journal of Clinical Oncology, 1996, v. 26, n. 2, p. 59, doi. 10.1093/oxfordjournals.jjco.a023185
- By:
- Publication type:
- Article
A network biology approach evaluating the anticancer effects of bortezomib identifies SPARC as a therapeutic target in adult T-cell leukemia cells.
- Published in:
- Advances & Applications in Bioinformatics & Chemistry, 2008, v. 1, p. 85
- By:
- Publication type:
- Article
Impact on cell to plasma ratio of miR-92a in patients with acute leukemia: in vivo assessment of cell to plasma ratio of miR-92a.
- Published in:
- BMC Research Notes, 2010, v. 3, p. 347, doi. 10.1186/1756-0500-3-347
- By:
- Publication type:
- Article
Up-regulated exosomal miRNA-140-3p in CML patients with musculoskeletal pain associated with discontinuation of tyrosine kinase inhibitors.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Leukocytosis is linked to thrombosis at diagnosis, while JAK2 V617F mutation is associated with thrombosis during the course of essential thrombocythemia.
- Published in:
- 2008
- By:
- Publication type:
- letter
Telomerase activity in lung cancer cells obtained from bronchial washings.
- Published in:
- 1998
- By:
- Publication type:
- journal article
Chromatin Regulation by HP1γ Contributes to Survival of 5-Azacytidine-Resistant Cells.
- Published in:
- Frontiers in Pharmacology, 2018, p. N.PAG, doi. 10.3389/fphar.2018.01166
- By:
- Publication type:
- Article
The relationship between telomere length and therapy-associated cytogenetic responses in patients with chronic myeloid leukemia.
- Published in:
- 1997
- By:
- Publication type:
- journal article
Cytogenetic and clinical findings of myelodysplastic syndromes with a poor prognosis. An experience with 97 cases.
- Published in:
- 1992
- By:
- Publication type:
- journal article
Establishment of a new Hodgkin's cell line (HD-70) of B-cell origin.
- Published in:
- 1992
- By:
- Publication type:
- journal article
Clinical and cytogenetic characteristics of myelodysplastic syndromes developing myelofibrosis.
- Published in:
- 1991
- By:
- Publication type:
- journal article
ASCORBATE FOR THE TREATMENT OF IDIOPATHIC THROMBOCYTOPENIC PURPURA.
- Published in:
- British Journal of Haematology, 1990, v. 75, n. 4, p. 623, doi. 10.1111/j.1365-2141.1990.tb07814.x
- By:
- Publication type:
- Article
TRISOMY 11 IN NONLYMPHOCYTIC NEOPLASIA.
- Published in:
- British Journal of Haematology, 1988, v. 69, n. 3, p. 420, doi. 10.1111/j.1365-2141.1988.tb02384.x
- By:
- Publication type:
- Article
Idiopathic neutropenia with fewer than 5% dysplasia may be a distinct entity of idiopathic cytopenia of undetermined significance.
- Published in:
- 2010
- By:
- Publication type:
- Letter
A combination of semiquantitative telomerase assay and in-cell telomerase activity measurement using exfoliated urothelial cells for the detection of urothelial neoplasia.
- Published in:
- 1998
- By:
- Publication type:
- journal article
Sustained upregulation of effector natural killer cells in chronic myeloid leukemia after discontinuation of imatinib.
- Published in:
- Cancer Science, 2013, v. 104, n. 9, p. 1146, doi. 10.1111/cas.12216
- By:
- Publication type:
- Article
The oral iron chelator deferasirox represses signaling through the mTOR in myeloid leukemia cells by enhancing expression of REDD1.
- Published in:
- Cancer Science, 2009, v. 100, n. 5, p. 970, doi. 10.1111/j.1349-7006.2009.01131.x
- By:
- Publication type:
- Article